<?xml version="1.0" encoding="UTF-8"?>
<p class="p">However, a recent meta-analysis of randomized controlled trial (39,195 subjects; median duration of treatment 11.5 months; median dose of niacin 2 g/day in monotherapy or in combination with other component versus placebo/usual care or other component alone) showed no reduction with niacin in mortality, cardiovascular mortality, fatal or non-fatal myocardial infarction nor fatal or non-fatal strokes but niacin was associated with side effects [
 <xref rid="B149-nutrients-11-01299" ref-type="bibr" class="xref">149</xref>].
</p>
